VCEL Return on Tangible Equity | VERICEL CORPORATION

VERICEL CORPORATION (VCEL) Return on Tangible Equity

2026-06-30: Return Tang Equity 6.64%.
2026-03-31: Return Tang Equity 6.12%.
2025-12-31: Return Tang Equity 4.73%.
2025-09-30: Return Tang Equity 4.14%.

Complete source-backed return tang equity history.

Available history: 2010-06-30 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	6.64%
2026-03-31	6.12%
2025-12-31	4.73%
2025-09-30	4.14%
2025-06-30	2.36%
2025-03-31	1.03%
2024-12-31	3.63%
2024-09-30	1.41%
2024-06-30	0.33%
2024-03-31	0.20%
2023-12-31	-1.45%
2023-09-30	-5.20%
2023-06-30	-6.87%
2023-03-31	-9.17%
2022-12-31	-9.04%
2022-09-30	-10.18%
2022-06-30	-9.41%
2022-03-31	-6.54%
2021-12-31	-4.38%
2021-09-30	0.14%
2021-06-30	5.91%
2021-03-31	3.11%
2020-12-31	2.18%
2020-09-30	0.13%
2020-06-30	-0.00%
2020-03-31	-10.70%
2019-12-31	-8.92%
2019-09-30	-14.77%
2019-06-30	-21.51%
2019-03-31	-3.31%
2018-12-31	-8.18%
2018-09-30	-14.27%
2018-06-30	-19.83%
2018-03-31	-83.21%
2017-12-31	-87.16%
2017-09-30	-169.43%
2017-06-30	-222.26%
2017-03-31	-200.80%
2016-12-31	-88.94%
2016-09-30	-210.47%
2016-06-30	-111.80%
2016-03-31	-92.36%
2015-12-31	-85.05%
2015-09-30	-58.92%
2015-06-30	-59.96%
2015-03-31	-65.75%
2014-12-31	-61.40%
2014-09-30	-59.29%
2014-06-30	2751.65%
2014-03-31	-426.45%
2013-12-31	-401.18%
2013-09-30	-391.03%
2013-06-30	56.33%
2013-03-31	69.90%
2012-12-31	91.82%
2012-09-30	103.95%
2012-06-30	103.88%
2012-03-31	111.10%
2011-12-31	151.63%
2011-09-30	185.03%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	4.73%
2024-12-31	3.63%
2023-12-31	-1.45%
2022-12-31	-9.04%
2021-12-31	-4.38%
2020-12-31	2.18%
2019-12-31	-8.93%
2018-12-31	-8.19%
2017-12-31	-88.09%
2016-12-31	-89.79%
2015-12-31	-85.05%
2014-12-31	-61.40%
2013-12-31	-401.18%
2012-12-31	91.82%
2011-12-31	151.63%
2010-06-30	-98.49%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
RECURSION PHARMACEUTICALS, INC. (RXRX)	United States	$2.080B	-3.78
Kodiak Sciences Inc. (KOD)	United States	$2.090B	-10.12
ADMA BIOLOGICS, INC. (ADMA)	United States	$2.131B	11.16
BIOCRYST PHARMACEUTICALS INC (BCRX)	United States	$2.175B	-6.63
Vir Biotechnology, Inc. (VIR)	United States	$1.814B	-6.85
NOVAVAX INC (NVAX)	United States	$1.748B	-6.26
Hemab Therapeutics Holdings, Inc. (COAG)	United States	$1.672B
Greenland Mines Ltd (GRML)	United States	$2.362B
Immunocore Holdings plc (IMCR)		$1.613B	-90.43
Taysha Gene Therapies, Inc. (TSHA)	United States	$1.564B	-14.80